• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

骨质疏松症的预防

Prevention of osteoporosis.

作者信息

Lindsay R

出版信息

Clin Orthop Relat Res. 1987 Sep(222):44-59.

PMID:3304759
Abstract

Osteoporosis is a major public health problem, and its prevalence may be increasing. Unfortunately, once spinal fractures occur, the treatment of osteoporosis is less than satisfactory. Prevention is thus the preferred approach. To initiate a prevention program would require identification of those at greatest risk. Usually, small, thin, white or Asian women who have had an early menopause (or oophorectomy) can be considered most at risk. Other factors may include low calcium intake, inactivity, alcohol and cigarette consumption, and nulliparity. For those clinically thought to be at greatest risk, bone mass measurements may be used to more clearly define the population for whom preventive therapy would be indicated. Prevention consists of dietary and lifestyle alterations, primarily increases in calcium intake and exercise, and the judicious use of estrogens. Estrogen therapy remains the single most effective method for prevention of bone loss.

摘要

骨质疏松症是一个重大的公共卫生问题,其患病率可能正在上升。不幸的是,一旦发生脊柱骨折,骨质疏松症的治疗效果并不理想。因此,预防是首选方法。启动预防计划需要识别出风险最高的人群。通常,身材矮小、消瘦、白人或亚洲女性,且过早绝经(或接受过卵巢切除术)的人群被认为风险最高。其他因素可能包括钙摄入量低、缺乏运动、饮酒和吸烟以及未生育。对于临床认为风险最高的人群,可以使用骨量测量来更明确地界定适合进行预防性治疗的人群。预防措施包括饮食和生活方式的改变,主要是增加钙摄入量和进行运动,以及合理使用雌激素。雌激素疗法仍然是预防骨质流失的最有效方法。

相似文献

1
Prevention of osteoporosis.骨质疏松症的预防
Clin Orthop Relat Res. 1987 Sep(222):44-59.
2
Osteoporosis: new hope for the future.骨质疏松症:未来的新希望。
Int J Fertil Womens Med. 1997 Jul-Aug;42(4):245-54.
3
Prevention of postmenopausal osteoporosis.绝经后骨质疏松症的预防。
Obstet Gynecol Clin North Am. 1987 Mar;14(1):63-76.
4
Osteoporosis: preventive strategies.骨质疏松症:预防策略
Int J Fertil Womens Med. 1998 Mar-Apr;43(2):56-64.
5
[Prevention of osteoporosis. Review of recent literature].
Fortschr Med. 1983 Apr 28;101(16):743-5.
6
Osteoporosis: significance, risk factors and treatment.
Nurse Pract. 1986 Sep;11(9):16-20, 25-7, 30 passim.
7
Pathogenesis and management of primary osteoporosis.原发性骨质疏松症的发病机制与管理
Clin Pharm. 1986 Aug;5(8):639-59.
8
Bone mass and bone loss in the elderly: a special case?老年人的骨量与骨质流失:一种特殊情况?
Int J Fertil Menopausal Stud. 1993;38 Suppl 2:92-7.
9
Osteoporosis management.骨质疏松症管理
Int J Fertil Womens Med. 1999 Sep-Oct;44(5):241-9.
10
Management of osteoporosis in postmenopausal women: 2006 position statement of The North American Menopause Society.绝经后女性骨质疏松症的管理:北美更年期协会2006年立场声明
Menopause. 2006 May-Jun;13(3):340-67; quiz 368-9. doi: 10.1097/01.gme.0000222475.93345.b3.

引用本文的文献

1
Bone loss. Epidemiology of bone loss.骨质流失。骨质流失的流行病学。
Arthritis Res. 2000;2(6):441-5. doi: 10.1186/ar125. Epub 2000 Aug 3.
2
The effect of intranasal salmon calcitonin on postmenopausal bone turnover as assessed by biochemical markers: evidence of maximal effect after 8 weeks of continuous treatment.通过生化标志物评估鼻内注射鲑鱼降钙素对绝经后骨转换的影响:连续治疗8周后达到最大效应的证据。
Calcif Tissue Int. 1996 Apr;58(4):216-20. doi: 10.1007/BF02508638.
3
The effects of a 5-month physical training on iliac bone morphology in monkeys.
为期5个月的体育训练对猴子髂骨形态的影响。
Eur J Appl Physiol Occup Physiol. 1993;67(1):1-6. doi: 10.1007/BF00377695.
4
Perimenopausal women's views on taking hormone replacement therapy to prevent osteoporosis.围绝经期女性对采用激素替代疗法预防骨质疏松症的看法。
BMJ. 1990 Mar 24;300(6727):786-8. doi: 10.1136/bmj.300.6727.786.
5
Bone death in hip fracture in the elderly.老年人髋部骨折中的骨坏死
Calcif Tissue Int. 1990 Nov;47(5):270-5. doi: 10.1007/BF02555908.
6
Significance of osteoporosis: a growing international health care problem.骨质疏松症的重要性:一个日益严重的国际医疗保健问题。
Calcif Tissue Int. 1991;49 Suppl:S5-7. doi: 10.1007/BF02555078.